⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Adam RosenbluthMD

Cardiology · New York, NY 10021

NPI: 1083766729

Share:

24

🟡 Moderate

Risk Flags

High long-acting opioid rate vs peersElevated antipsychotic prescribing (65+)Opioid + benzodiazepine co-prescriber

Risk indicators are statistical patterns, not allegations. Learn more

8,766

Total Claims

$1.6M

Drug Cost

571

Beneficiaries

$2,871

Cost/Patient

Risk Score Breakdown 24/100

Low (0)Moderate (15)Elevated (30)High (50+)
Long-acting opioid rate+8
Opioid + benzodiazepine combo+8
Elderly antipsychotic prescribing+5

Score components are additive. Read full methodology

Peer Comparison vs. 18,720 Cardiology providers

+88%

Cost per patient vs peers

$2,871 vs $1,524 avg

+73%

Brand preference vs peers

23.7% vs 13.7% avg

⚠️ Opioid + Benzodiazepine Co-Prescriber

This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.

🔎 Data Overview

⚠️

This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

1.3%

Opioid Rate

113

Opioid Claims

$3,362

Opioid Cost

12.4%

Long-Acting Rate

Brand vs Generic

76% generic

Brand: 2,054 claims · $1.4M

Generic: 6,622 claims · $212K

Top Prescribed Drugs

Drug (Generic)ClaimsCost
Semaglutide319$385K
Apixaban171$130K
Dapagliflozin Propanediol101$92K
Dulaglutide64$89K
Rifaximin24$61K
Empagliflozin42$54K
Dapaglifloz Propaned/Metformin58$51K
Mirabegron69$45K
Dronedarone Hcl36$36K
Rivaroxaban31$35K
Droxidopa13$26K
Alirocumab37$25K
Tirzepatide21$23K
Rsvpref3 Antigen/As01e/Pf63$20K
Linaclotide37$20K

Prescribing Profile

147

Unique Drugs

$338K

IRA Negotiated Drugs

$498K

GLP-1 Drugs

24.0

Anomaly Score

Patient Profile

80

Avg Age

59%

Female

1.01

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data